Literature DB >> 2300065

Dose-response relationship for the induction of structural chromosome aberrations in human spermatozoa after in vitro exposure to tritium beta-rays.

Y Kamiguchi1, H Tateno, K Mikamo.   

Abstract

The effects of tritium (HTO) beta-rays on human sperm chromosomes were studied using our interspecific in vitro fertilization system between human spermatozoa and zona-free hamster oocytes. Semen samples were treated with media containing 1.53-24.3 mCi/ml HTO for about 80 min. 1290 spermatozoa from the controls and 1842 spermatozoa from the irradiated groups were karyotyped. The incidence of spermatozoa with structural chromosome aberrations increased linearly with increasing dosage. Breakage-type aberrations occurred far more frequently than exchange-type. Chromosome-type aberrations appeared far more frequently than chromatid-type. All of these types of aberrations showed linear dose-dependent increases. The RBE values of HTO beta-rays relative to X-rays were calculated for the above-mentioned 5 indices, respectively. Their RBE values ranged from 1.89 to 3.00 when the absorbed dose was estimated to be the minimum, whereas the values ranged between 1.04 and 1.65 when the absorbed dose was estimated to be the maximum.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2300065     DOI: 10.1016/0027-5107(90)90068-f

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  2 in total

Review 1.  Systematic review of experimental studies on the relative biological effectiveness of tritium.

Authors:  M P Little; B E Lambert
Journal:  Radiat Environ Biophys       Date:  2007-12-11       Impact factor: 1.925

2.  The Role of miR-34a in Tritiated Water Toxicity in Human Umbilical Vein Endothelial Cells.

Authors:  Feng Mei Cui; Liang Liu; Lu Lin Zheng; Guang Liang Bao; Yu Tu; Liang Sun; Wei Zhu; Jian Ping Cao; Ping Kun Zhou; Qiu Chen; Yong Ming He
Journal:  Dose Response       Date:  2016-03-30       Impact factor: 2.658

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.